Insife, a Qinecsa company, is a leading provider of pharmacovigilance solutions, offering a comprehensive platform and expert consulting to help pharmaceutical and biotech companies efficiently navigate drug safety processes. With 130 safety experts worldwide, Insife provides the largest Europe-based pharmacovigilance services and solutions in the industry. The company's flagship product HALOPV is an end-to-end system to manage multivigilance processes from operational to scientific tasks. Insife also offers regulatory intelligence, hosting services, and strategic consulting to deliver outstanding domain expertise across the US, Europe, and Asia. With a commitment to transforming drug safety through innovation, Insife is changing the technology landscape for pharmacovigilance worldwide.
| Website | https://www.qinecsa.com |
| Revenue | $5.3 million |
| Employees | 30 (22 on RocketReach) |
| Founded | 2017 |
| Phone | +45 53 60 89 83 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmacovigilance, Drug Safety, Safety Solutions, Regulatory Compliance, Pharmaceutical Consulting, Biotech Consulting, Pv Software, Safety Reporting, Risk Management, Signal Detection, Medical Affairs, Pharmacovigilance Outsourcing, Global Safety, Drug Development, Data Management, Compliance Solutions, Expert Consulting |
Looking for a particular Insife employee's phone or email?
The Insife annual revenue was $5.3 million in 2026.
Martin Holm-Petersen is the CEO of Insife.
22 people are employed at Insife.